Ledger.Open graph →
SEC Form D · filed December 18, 2017

SignPath Pharma, Inc

Offering
$5.0M
Sold
$235K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SANDY, UT
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Kai Larson · Sandy, UTExecPeter P. Sordillo · Sandy, UTExecJack P. Levine, Cpa · Quakertown, PADirectorKenneth S. Kranzberg · New York, NYExecBeth P. Hecht · Sandy, UTDirectorRobert P. Saguso · Sandy, UTDirectorArthur P. Bollon, Ph.D · Quakertown, PADirectorLouis Laskis · TEMPE, AZExecBeth P. Hecht · Sandy, UTDirectorRobert P. Saguso · Sandy, UTDirectorPeter P. Sordillo · Sandy, UTExecArthur P. Bollon, Ph.D · Quakertown, PADirectorJack P. Levine, Cpa · Quakertown, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗